thoughts , page-13

I agree CR8,
The tech is exciting but the competition for Hep c cures is much greater than previously seen. New treatments (still not as good as a one off shot if it works) coming into market now against BLT still very early in clinical development, still preclin with Hep B and AMD, ideas about possible other uses. Like others I have made money here (in $1, out $2 -great!) but it looks like it is falling back to low $1 - and so it should with the dilution and so far to go to prove it's worth.

cheers all

I have noted my last couple of posts on HC have been downbeat - must be depressed!

DYOR, I know little to nothing about anything -still!